{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T02:12:02Z","timestamp":1792721522110,"version":"4.5.0"},"reference-count":26,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2020,9,2]],"date-time":"2020-09-02T00:00:00Z","timestamp":1599004800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005762","name":"National Taiwan University Hospital","doi-asserted-by":"publisher","award":["108-S4228"],"award-info":[{"award-number":["108-S4228"]}],"id":[{"id":"10.13039\/501100005762","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0238201","type":"journal-article","created":{"date-parts":[[2020,9,2]],"date-time":"2020-09-02T17:38:41Z","timestamp":1599068321000},"page":"e0238201","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":46,"title":["Safety range of free valproic acid serum concentration in adult patients"],"prefix":"10.1371","volume":"15","author":[{"given":"Yu-Ju","family":"Tseng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shih-Ying","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Hsuan","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen-Yu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuo-Chuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9517-2176","authenticated-orcid":true,"given":"Chien-Chih","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2020,9,2]]},"reference":[{"issue":"7","key":"pone.0238201.ref001","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1111\/j.1528-1167.2008.01561.x","article-title":"Antiepileptic drugs\u2014best practice guidelines for therapeutic drug monitoring: a position paper by the subcommission on therapeutic drug monitoring, ILAE Commission on Therapeutic Strategies","volume":"49","author":"PN Patsalos","year":"2008","journal-title":"Epilepsia"},{"issue":"10","key":"pone.0238201.ref002","doi-asserted-by":"crossref","first-page":"669","DOI":"10.2165\/00023210-200216100-00003","article-title":"Basic pharmacology of valproate: a review after 35 years of clinical use for the treatment of epilepsy.","volume":"16","author":"W. Loscher","year":"2002","journal-title":"CNS Drugs."},{"issue":"11","key":"pone.0238201.ref003","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1176\/ajp.2006.163.11.1891","article-title":"An interaction between aspirin and valproate: the relevance of plasma protein displacement drug-drug interactions.","volume":"163","author":"NB Sandson","year":"2006","journal-title":"Am J Psychiatry"},{"issue":"8","key":"pone.0238201.ref004","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1002\/phar.1965","article-title":"Clinical Importance of Monitoring Unbound Valproic Acid Concentration in Patients with Hypoalbuminemia.","volume":"37","author":"M Dore","year":"2017","journal-title":"Pharmacotherapy."},{"issue":"1","key":"pone.0238201.ref005","doi-asserted-by":"crossref","first-page":"67","DOI":"10.2165\/00003088-198005010-00002","article-title":"Clinical pharmacokinetics of valproic acid.","volume":"5","author":"R Gugler","year":"1980","journal-title":"Clin Pharmacokinet"},{"issue":"1","key":"pone.0238201.ref006","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1097\/00007691-197901000-00011","article-title":"Valproic acid: in vitro plasma protein binding and interaction with phenytoin.","volume":"1","author":"JA Cramer","year":"1979","journal-title":"Therapeutic drug monitoring."},{"issue":"5","key":"pone.0238201.ref007","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1097\/FTD.0000000000000546","article-title":"Therapeutic Drug Monitoring of Antiepileptic Drugs in Epilepsy: A 2018 Update.","volume":"40","author":"PN Patsalos","year":"2018","journal-title":"Therapeutic drug monitoring."},{"key":"pone.0238201.ref008","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.seizure.2018.04.012","article-title":"Determinants of free serum valproate concentration: A prospective study in patients on divalproex sodium monotherapy.","volume":"59","author":"W Nasreddine","year":"2018","journal-title":"Seizure"},{"issue":"2","key":"pone.0238201.ref009","doi-asserted-by":"crossref","first-page":"121","DOI":"10.2146\/ajhp140191","article-title":"Comparison of free fraction serum valproic acid concentrations between inpatients and outpatients.","volume":"72","author":"HG Gibbs","year":"2015","journal-title":"Am J Health Syst Pharm"},{"issue":"4","key":"pone.0238201.ref010","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1002\/phar.1912","article-title":"Valproate Protein Binding Is Highly Variable in ICU Patients and Not Predicted by Total Serum Concentrations: A Case Series and Literature Review.","volume":"37","author":"RR Riker","year":"2017","journal-title":"Pharmacotherapy."},{"issue":"2","key":"pone.0238201.ref011","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s12028-018-0627-4","article-title":"Accuracy of Valproic Acid Concentration Correction Based on Serum Albumin.","volume":"30","author":"A Drisaldi","year":"2019","journal-title":"Neurocritical care."},{"issue":"4 Suppl","key":"pone.0238201.ref012","first-page":"1","article-title":"Practice guideline for the treatment of patients with bipolar disorder (revision).","volume":"159","year":"2002","journal-title":"The American journal of psychiatry"},{"key":"pone.0238201.ref013","volume-title":"Mosby\u2019s Diagnostic & Laboratory Test Reference","author":"KD Pagana","year":"2019","edition":"14"},{"key":"pone.0238201.ref014","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jcrc.2016.06.023","article-title":"Antiepileptic dosing for critically ill adult patients receiving renal replacement therapy","volume":"36","author":"KS Smetana","year":"2016","journal-title":"Journal of critical care"},{"key":"pone.0238201.ref015","unstructured":"Valproic Acid, Free and Total [Internet]. Laboratory Test Directory. [cited 2020 Apr 1] http:\/\/ltd.aruplab.com\/Tests\/Pub\/0099310."},{"issue":"2","key":"pone.0238201.ref016","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the probability of adverse drug reactions","volume":"30","author":"CA Naranjo","year":"1981","journal-title":"Clin Pharmacol Ther"},{"issue":"6","key":"pone.0238201.ref017","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1248\/bpb.35.971","article-title":"Correlation between plasma ammonia level and serum trough concentration of free valproic acid in patients with epilepsy","volume":"35","author":"H Itoh","year":"2012","journal-title":"Biol Pharm Bull"},{"issue":"1","key":"pone.0238201.ref018","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1176\/appi.ajp.158.1.128","article-title":"Occurrence of thrombocytopenia in psychiatric patients taking valproate.","volume":"158","author":"TJ Trannel","year":"2001","journal-title":"Am J Psychiatry"},{"issue":"5","key":"pone.0238201.ref019","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/01.jcp.0000088911.24613.0d","article-title":"Thrombocytopenia during valproic acid treatment in young patients with new-onset bipolar disorder.","volume":"23","author":"D De Berardis","year":"2003","journal-title":"J Clin Psychopharmacol"},{"issue":"11","key":"pone.0238201.ref020","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1592\/phco.21.17.1325.34418","article-title":"Prevalence and risk of thrombocytopenia with valproic acid: experience at a psychiatric teaching hospital.","volume":"21","author":"EL Conley","year":"2001","journal-title":"Pharmacotherapy"},{"issue":"3","key":"pone.0238201.ref021","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1111\/j.1528-1167.2007.01429.x","article-title":"Valproate-induced thrombocytopenia: a prospective monotherapy study","volume":"49","author":"W Nasreddine","year":"2008","journal-title":"Epilepsia"},{"issue":"1","key":"pone.0238201.ref022","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40268-017-0224-6","article-title":"The Risk of Thrombocytopenia During Valproic Acid Therapy: A Critical Summary of Available Clinical Data.","volume":"18","author":"M Buoli","year":"2018","journal-title":"Drugs R D."},{"key":"pone.0238201.ref023","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.genhosppsych.2019.05.005","article-title":"Risk factors for valproic acid induced hyperammonemia and its association with cognitive functions.","volume":"59","author":"B Duman","year":"2019","journal-title":"Gen Hosp Psychiatry"},{"issue":"11","key":"pone.0238201.ref024","doi-asserted-by":"crossref","first-page":"e66","DOI":"10.1097\/MD.0000000000000066","article-title":"Risk factors of hyperammonemia in patients with epilepsy under valproic acid therapy.","volume":"93","author":"YL Tseng","year":"2014","journal-title":"Medicine (Baltimore)."},{"issue":"3","key":"pone.0238201.ref025","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.eplepsyres.2012.04.001","article-title":"Risk factors for hyperammonemia associated with valproic acid therapy in adult epilepsy patients","volume":"101","author":"Y Yamamoto","year":"2012","journal-title":"Epilepsy research"},{"issue":"11","key":"pone.0238201.ref026","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1111\/j.1528-1167.2011.03279.x","article-title":"Transient hyperammonemia in seizures: a prospective study","volume":"52","author":"TY Hung","year":"2011","journal-title":"Epilepsia"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0238201","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,2]],"date-time":"2020-09-02T17:38:55Z","timestamp":1599068335000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0238201"}},"subtitle":[],"editor":[{"given":"Emilio","family":"Russo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2020,9,2]]},"references-count":26,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2020,9,2]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0238201","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,2]]}}}